Long‐Term Survival in Patients Treated with Cardiac Resynchronization Therapy: A 3‐Year Follow‐Up Study from the InSync/InSync ICD Italian Registry

Gasparini, Maurizio; Lunati, Maurizio; Santini, Massimo; Tritto, Massimo; Curnis, Antonio; Bocchiardo, Mario; Vincenti, Antonio; Pistis, Gianfranco; Valsecchi, Sergio; Denaro, Alessandra

doi:10.1111/j.1540-8159.2006.00485.x

Cited by 37 publications

(31 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finally, there were no significant differences in CRT-related complications in both patient groups. Of note, serious complications such as cardiac tamponade (reported in 0.5-1% in COMPANION 4 and the Italian InSync Registry 18 ), infection and explantation (1.3% in MIRACLE, 2 1% in CARE-HF 3 ), or peri-procedural mortality (0.8% in COMPANION 4 ) were not observed in our patients. A dissection between the wall of the vena cava superior and ingrown old ICD leads occurred in a patient undergoing CRT upgrade but remained without clinical sequelae, and did not prevent continuation of the procedure and successful CRT implantation.…”

Section: Feasibility and Safety Of Cardiac Resynchronization Therapy mentioning

confidence: 85%

“…13 From the other two studies, one did not include a control group, and was therefore purely descriptive in nature. 18 Marai et al compared 25 patients with upgrade procedure with 73 patients with de novo CRT implantations. 16 They reported similar changes in echocardiographic parameters, NYHA functional status, and 6 min walking test.…”

Section: Feasibility and Safety Of Cardiac Resynchronization Therapy mentioning

confidence: 99%

See 1 more Smart Citation

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate

et al. 2007

View full text Add to dashboard Cite

Aims Cardiac resynchronization therapy (CRT) is indicated in patients with heart failure and bundle branch block. It is less clear whether this includes patients with pre-existing right ventricular pacemaker/ defibrillator systems, particularly with respect to implantation success and clinical benefit. Methods and results In consecutive patients scheduled for CRT, we prospectively compared implantation success, procedural parameters, and clinical response in 'de novo' vs. upgrade procedures of previously implanted right ventricular systems. CRT implantation was attempted in 79 consecutive patients (64 + 11 years, 63 male, 38 ischaemic, 41 non-ischaemic cardiomyopathy). De novo implantation was performed in 61 patients, upgrade procedures in 18 patients. Implant success (92 vs. 94%, P ¼ 1.00), procedure duration (153 + 43 vs. 164 + 65 min, P ¼ 0.51), fluoroscopy time (25 + 18 vs. 32 + 22 min, P ¼ 0.18) or dose (40 + 31 vs. 52 + 49 Gy/cm 2 , P ¼ 0.35), and response rate (66 vs. 59%, P ¼ 0.5) were comparable for both groups. Conclusion Procedural aspects, implantation success, and clinical response to CRT were comparable for patients undergoing de-novo vs. upgrade procedures. Accordingly, patient selection for upgrading should be the same as for new CRT implantation.

show abstract

Section: Feasibility and Safety Of Cardiac Resynchronization Therapy mentioning

confidence: 85%

Section: Feasibility and Safety Of Cardiac Resynchronization Therapy mentioning

confidence: 99%

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate

et al. 2007

View full text Add to dashboard Cite

show abstract

“…1 About 20% of patients treated with cardiac resynchronization therapy (CRT) are in AF. 2,3 Despite the high prevalence of AF in patients with HF and the fact that many meet the criteria for CRT, randomized controlled trials have excluded these patients in most cases. 4 Thus, the effect of this therapy in patients with AF is still controversial.…”

Section: Introductionmentioning

confidence: 99%

Cardiac resynchronization therapy in patients with atrial fibrillation: A meta-analysis

Lopes

Pereira

Barra

2014

Revista Portuguesa de Cardiologia

View full text Add to dashboard Cite

show abstract

“…In Europe, 24% of CRT recipients are women [78], and the corresponding figure in the USA is 22-26% [73], with women comprising 17-24% [79][80][81][82] in larger registry studies of CRT. Although CRT appears to be underutilized in women, the reason for this is unclear.…”

Section: Gender Aspectsmentioning

confidence: 99%

Cardiac resynchronization therapy: a breakthrough in heart failure management

Ståhlberg

Lund

Zabarovskaja

et al. 2012

Journal of Internal Medicine

View full text Add to dashboard Cite

Abstract. Stå hlberg M, Lund LH, Zabarovskaja S, Gadler F, Braunschweig F, Linde C (Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden). Cardiac resynchronization therapy: a breakthrough in heart failure management (Review). J Intern Med 2012; 272: 330-343.Heart failure is now considered an epidemic. In patients with heart failure, electrical and mechanical dyssynchrony, evident primarily as prolongation of the QRS-complex on the surface electrocardiogram, is associated with detrimental effects on the cardiovascular system at several levels. In the past 10 years, studies have demonstrated that by stimulating both cardiac ventricles simultaneously, or almost simultaneously [cardiac resynchronization therapy (CRT)], the adverse effects of dyssynchrony can be overcome. Here, we provide a comprehensive overview of different aspects of CRT including the rationale behind and evidence for efficacy of the therapy. Issues with regard to gender effects and patient follow-up as well as a number of unresolved concerns will also be discussed.

show abstract

Long‐Term Survival in Patients Treated with Cardiac Resynchronization Therapy: A 3‐Year Follow‐Up Study from the InSync/InSync ICD Italian Registry

Cited by 37 publications

References 38 publications

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate

Cardiac resynchronization therapy in patients with atrial fibrillation: A meta-analysis

Cardiac resynchronization therapy: a breakthrough in heart failure management

Contact Info

Product

Resources

About